ERBB2 and neoplasm: Therefore, in case B, HER2 amplification may be a progression event in a clonal tumour cell population, as recently reported (Hanna et al, 2007; Kostopoulou et al, 2007; Cottu et al, 2008; Apple et al, 2009).